Versant Capital Management »

Denali Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2k 109 20.52
2023-12-31 $172 8 21.50
2023-06-30 $531 18 29.50
2019-09-30 $0 39 0.00

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Ishares S&p Global Energy Etf (IXC)
Microsoft Stock (MSFT)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Exxon Mobil Corp Stock (XOM)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Spdr Gold Minishares Trust Etf (GLDM)
Avantis U.s. Equity Etf Etf (AVUS)
Spdr S&p Global Natural Resources Etf Etf (GNR)

View all positions for Versant Capital Management

Top funds holding Denali Therapeutics

Baillie Gifford & Co
Vanguard Group
Wellington Management Company
Crestline Management
Baker Bros. Advisors
T. Rowe Price Associates
Flagship Ventures Management
Bank of New York Mellon
Marshall Wace
Credit Suisse
Federated Investors
Casdin Capital
Gilder, Gagnon, Howe & Co
Norges Bank Investment Management
Yiheng Capital

View all funds holding Denali Therapeutics